---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-017941"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2025-10-14T23:59:59+00:00"
generated_at: "2026-05-17T04:02:23.280824+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Microbot partners with US logistics provider; LIBERTY launch on track for Q4 2025

## Summary
- Partnered with an experienced medtech 3PL company for inventory management and order fulfillment.
- Limited market release of FDA-cleared LIBERTY Endovascular Robotic System expected Q4 2025.
- Broader commercial launch targeted for April 2026 at the Society of Interventional Radiology conference.
- Michal Ahuvia, Director of Operations, says logistics support strengthens go-to-market efficiency.

## SEC filing metadata
- accession: 0001493152-25-017941
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2025-10-14T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315225017941/0001493152-25-017941-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315225017941/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-017941
- JSON: https://secwatch.observer/filing/0001493152-25-017941.json
- Plain text: https://secwatch.observer/filing/0001493152-25-017941.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.